These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 11097594)
21. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750 [TBL] [Abstract][Full Text] [Related]
26. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Zaki AA; Farid SF Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215 [TBL] [Abstract][Full Text] [Related]
27. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia. Huerva V; Mateo AJ; Mangues I; Jurjo C Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902 [TBL] [Abstract][Full Text] [Related]
28. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. Venkateswaran N; Mercado C; Galor A; Karp CL Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241 [TBL] [Abstract][Full Text] [Related]
32. A pulse-dose topical 1% 5-fluorouracil treatment regimen in a young dog with corneal squamous cell carcinoma. Overton TL; Allbaugh RA; Whitley D; Ben-Shlomo G; Griggs A; Tofflemire KL; Whitley EM Vet Ophthalmol; 2015 Jul; 18(4):350-4. PubMed ID: 25270617 [TBL] [Abstract][Full Text] [Related]
33. 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea. Al-Barrag A; Al-Shaer M; Al-Matary N; Al-Hamdani M Clin Ophthalmol; 2010 Jul; 4():801-8. PubMed ID: 20689797 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia. Kato JM; Ballalai PL; de Lima PP; Santo RM Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493 [TBL] [Abstract][Full Text] [Related]
35. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia. Lee JH; Kim YH; Kim MS; Kim EC Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714 [TBL] [Abstract][Full Text] [Related]
36. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Di Pascuale MA; Espana EM; Tseng SC Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965 [TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Hirst LW Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666 [TBL] [Abstract][Full Text] [Related]
39. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]